UROTHELIAL BLADDER CANCER
Clinical trials for UROTHELIAL BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL BLADDER CANCER trials appear
Sign up with your email to follow new studies for UROTHELIAL BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer pill targets genetic weakness in Hard-to-Treat tumors
Disease control CompletedThis study tested a new drug called brigimadlin (BI 907828) in 99 adults with advanced cancers of the bile duct, pancreas, lung, or bladder that have a specific genetic change (MDM2 amplification). Participants took the drug as a tablet once every 3 weeks. The goal was to see if …
Matched conditions: UROTHELIAL BLADDER CANCER
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control CompletedThis study tested a new drug called DF1001 in 270 adults with advanced solid tumors that have spread or cannot be removed. The drug works by helping the body's immune cells attack cancer cells. The trial first found the safest dose, then tested it alone or with other cancer drugs…
Matched conditions: UROTHELIAL BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC